Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,36 USD | 0,00 % | -2,16 % | +9,68 % |
Resumen de negocios
Número de empleados: 167
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 292 | 100,0 % | 195 | 100,0 % | -33,46 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 292 | 100,0 % | 195 | 100,0 % | -33,46 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
John Butler
CEO | Chief Executive Officer | 59 | 01/07/13 |
Tracey Vetterick
ADM | Chief Administrative Officer | - | 01/04/22 |
Michel Dahan
COO | Chief Operating Officer | 45 | 01/01/13 |
Steven Burke
CTO | Chief Tech/Sci/R&D Officer | 63 | 17/06/19 |
Chief Tech/Sci/R&D Officer | - | - | |
Corporate Officer/Principal | - | - | |
Carolyn Rucci
LAW | General Counsel | - | 01/01/21 |
Meredith Bowman
HRO | Human Resources Officer | - | 01/05/22 |
Christian Barnes
PRN | Corporate Officer/Principal | - | - |
Nicholas Grund
PRN | Corporate Officer/Principal | 54 | 09/01 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Rogers
BRD | Director/Board Member | 64 | 12/12/18 |
Adrian Adams
CHM | Chairman | 73 | 12/12/18 |
Director/Board Member | 65 | 16/02/21 | |
John Butler
CEO | Chief Executive Officer | 59 | 01/07/13 |
Steven Gilman
BRD | Director/Board Member | 71 | 12/12/18 |
Ronald Frieson
BRD | Director/Board Member | 65 | 01/11/21 |
Cynthia Smith
BRD | Director/Board Member | 55 | 28/08/18 |
Myles Wolf
BRD | Director/Board Member | 53 | 06/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 209 372 275 | 187 998 029 ( 89,79 %) | 0 | 89,79 % |
Información de la empresa
Akebia Therapeutics, Inc.
245 First Street Suite 1400
02142, Cambridge
+617 871 2098
http://www.akebia.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,68 % | 285 M | |
+2,49 % | 96,73 mil M | |
-0,49 % | 21,31 mil M | |
-16,61 % | 21,21 mil M | |
-5,01 % | 18,79 mil M | |
-42,14 % | 16,37 mil M | |
-27,40 % | 13,68 mil M | |
+1,44 % | 13,44 mil M | |
+21,29 % | 10,98 mil M | |
-21,79 % | 8560,73 M |
- Bolsa de valores
- Acciones
- Acción AKBA
- Empresa Akebia Therapeutics, Inc.